New Delhi, August 14, 2025 — The Supreme Court has dismissed the Indian Medical Association’s (IMA) writ petition that accused Patanjali Ayurved of running misleading advertisements against modern medicine. The Bench disposed of the plea and indicated that the IMA could seek remedies before the appropriate forum if needed.
The move follows a turbulent year in which the Court had pulled up Patanjali’s founders over earlier contempt issues tied to advertising claims. While Thursday’s order closes the IMA’s current writ, the broader legal and regulatory scrutiny of health and cure claims in ads continues under consumer and drugs law frameworks. iprmentlaw.com
Why this matters
The ruling resets the legal battlefield. It does not bless misleading claims. Instead, it redirects the dispute to more suitable forums, such as consumer courts, regulators or High Courts, where evidence and compliance histories can be tested in detail. For brands and endorsers, the Supreme Court’s past guidance remains clear: claims must be truthful and substantiated. iprmentlaw.com
What’s next
Expect tighter self-regulation, sharper disclosures in wellness ads and swifter action against unverifiable cure claims. Doctors’ bodies and consumer groups may also recalibrate strategy, focusing on case-by-case enforcement through statutory authorities.
